Skip to Content

C25 (Rubraca 250 mg)

Generic Name: rucaparib

Pill with imprint C25 is White, Four-sided and has been identified as Rubraca 250 mg. It is supplied by Clovis Oncology, Inc..

Rubraca is used in the treatment of ovarian cancer and belongs to the drug class PARP inhibitors. Rubraca 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C25

Rubraca

Generic Name:
rucaparib
Imprint:
C25
Strength:
250 mg
Color:
White
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
PARP inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Clovis Oncology, Inc.
Manufacturer:
Clovis Oncology, Inc.
National Drug Code (NDC):
69660-0202

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide